Calcium Butyrate CAS 5743-36-2: The Gut Health Powerhouse Transforming Animal Nutrition
Calcium Butyrate CAS 5743-36-2 (calcium salt of butyric acid) is a next-generation feed additive that delivers the short-chain fatty acid butyrate—the primary energy source for colonocytes and a key regulator of intestinal health—in a stable, non-volatile, and easy-to-handle powder form. Our calcium butyrate features minimum 98% purity with optimized particle engineering for uniform feed distribution, serving poultry integrators, swine producers, and aquaculture operations across 30+ countries seeking antibiotic-free growth promotion and gut integrity enhancement.
Technical Highlights & Mechanisms of Action
1. Targeted Colon Butyrate Release: Our calcium butyrate utilizes a proprietary lipid-microencapsulation technology (hydrogenated vegetable oil coating, melting point 58–62°C) that protects >85% of butyrate through the stomach and small intestine, achieving targeted release in the hindgut where butyrate exerts its maximum trophic effect on colonocytes. This represents a 3–4× improvement over unprotected calcium butyrate, which dissociates prematurely in the acidic gastric environment.
2. Gut Barrier Integrity Enhancement: In broiler chicken trials (n=2,400, 42-day grow-out), calcium butyrate at 500 g/tonne feed increased tight junction protein (occludin and claudin-3) expression by 2.3-fold versus control, reduced plasma endotoxin (LPS) levels by 38%, and decreased intestinal permeability (FITC-dextran assay) by 41%—confirming robust gut barrier strengthening.
3. Antimicrobial Alternative Performance: Across 5 commercial broiler trials (total n > 50,000 birds), our encapsulated calcium butyrate at 500 g/tonne matched or exceeded the performance of antibiotic growth promoters (AGPs: bacitracin methylene disalicylate 50 g/tonne): body weight +3.8%, FCR improved 5.2 points (1.62 vs. 1.67), and mortality reduced 28% versus non-supplemented control.
4. Odor-Controlled Handling: Unlike sodium butyrate and free butyric acid, our calcium butyrate has minimal volatile odor (<0.5 ppm butyric acid in headspace at 25°C), enabling safe manual handling and eliminating worker complaints at feed mill blending stations.
Competitive Comparison
| Parameter | Our Ca Butyrate (Encapsulated) | Plain Ca Butyrate | Sodium Butyrate | Tributyrin (Liquid) |
|---|
| Butyric Acid Equivalent | ~72% | ~72% | ~80% | ~86% |
| Gastric Bypass | >85% (encapsulated) | <30% | <20% | >90% |
| Odor | Very Low | Moderate | High (pungent) | Very Low |
| Feed Stability (90d) | >95% retention | 85–90% | 80–85% | Liquid handling |
| Handling Form | Free-flowing powder | Powder | Hygroscopic powder | Liquid oil |
| Price ($/kg) | $8–12 | $4–6 | $5–8 | $15–22 |
| Cost-Benefit Ratio | | | | |
Target Customer Scenarios
Broiler Integrator — Brazil
A top-5 Brazilian poultry integrator (processing 2.5M birds/week) adopted our encapsulated calcium butyrate at 500 g/tonne across all antibiotic-free (ABF) production contracts. Key outcomes vs. previous ABF program: average daily gain +4.2g/bird/day, FCR reduced from 1.68 to 1.61, footpad dermatitis incidence reduced from 12% to 4%, and processing plant condemnations down 31%. Annual ROI calculated at 3.8:1. “The consistency across different farms and seasons was remarkable—we use it across all ABF contracts now.” — Nutrition Director.
Swine Nursery Operation — United States
A Midwest US swine system (50,000 sows) implemented our calcium butyrate in nursery diets (Phase 1–3, 500–750 g/tonne) post-zinc oxide phase-out. Results: post-weaning diarrhea incidence reduced 52%, average wean-to-finish mortality improved from 5.2% to 3.9%, and nursery exit weight increased 0.8 kg/pig. The nutrition team calculated $1.85/pig net return after additive cost.
Shrimp Aquaculture — Vietnam
A Vietnamese intensive shrimp (Litopenaeus vannamei) farm added our calcium butyrate at 0.2% in commercial feed for a 90-day production cycle. Outcomes: survival rate increased from 72% to 86%, FCR improved from 1.45 to 1.32, and Vibrio parahaemolyticus (EMS/AHPND) incidence reduced from 18% to 3% across 12 ponds. “The hepatopancreas health improvement was visible—stronger color, better lipid content, more consistent molting.” — Farm Technical Manager.
Industry Trends
- Global AGP Phase-Out Acceleration: With China’s 2020 AGP ban, EU’s 2022 veterinary medicines regulation, and US FDA GFI #213, the global butyrate feed additive market is projected to reach $580M by 2029 (CAGR 8.2%) as producers seek efficacious alternatives.
- Encapsulation Technology Premium: Encapsulated butyrate products command a 2–3× price premium over plain salts but deliver 3–5× greater biological efficacy, shifting the value proposition from “cost per kg” to “cost per unit of performance improvement.”
- Aquaculture Expansion: Shrimp and fish aquaculture represent the fastest-growing application segment (12.4% CAGR), driven by intensive production systems where gut health directly determines survival and profitability.
Your message must be between 20-3,000 characters!
